Literature DB >> 7396878

Mechanism of methaemoglobin reduction by human erythrocytes.

A Tomoda, M Ida, A Tsuji, Y Yoneyama.   

Abstract

The time course of methaemoglobin reduction in human erythrocytes treated with nitrite was studied at pH 7.4, 37 degrees C, in the presence or absence of Methylene Blue, and the changes in methaemoglobin, intermediate haemoglobins and oxyhaemoglobin during the reaction were analysed by isoelectric-focusing on Ampholine/polyacrylamide-gel plates. In both cases, with or without the dye, the intermediate haemoglobins were found to be present at (alpha 3+beta 2+)2 and (alpha 2+beta 3+)2 valency hybrids from their characteristic position on electrophoresis, but amounts changed consecutively with time. The amount of (alpha 3+beta 2+)2 was always greater than that of the (alpha 2+beta 3+)2 valency hybrid. This result is explained by the differences in redox potentials between alpha- and beta-chains in methaemoglobin tetramer. It was concluded that methaemoglobin was reduced in human erythrocytes through these two different pats: methaemoglobin leads to k+3 (alpha 2+beta 3+)2 leads to k+3 oxyhaemoglobin. The reaction rate constants k'"1 (= k+1+k+3) and k'+2(=k+2+k+4) were estimated from the changes in each component methaemoglobin, intermediate haemoglobins [(alpha 3+beta 2+)2+(alpha 2+beta 3+)2] and oxyhaemoglobin.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7396878      PMCID: PMC1161898          DOI: 10.1042/bj1880535

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  12 in total

1.  Hereditary methemoglobinemia in Alaskan Eskimos and Indians.

Authors:  E M SCOTT; D D HOSKINS
Journal:  Blood       Date:  1958-08       Impact factor: 22.113

2.  The oxidation-reduction stoichiometry and potential of microsomal cytochrome.

Authors:  S F VELICK; P STRITTMATTER
Journal:  J Biol Chem       Date:  1956-07       Impact factor: 5.157

3.  Analysis of met-form hemoglobin in glucose-deleted human red cells.

Authors:  A Tomoda; M Takeshita; Y Yoneyama
Journal:  FEBS Lett       Date:  1978-04-15       Impact factor: 4.124

4.  Purification of reduced pyridine nucleotide dehydrogenase from human erythrocytes and methemoglobin reduction by the enzyme.

Authors:  Y Sugita; S Nomura; Y Yoneyama
Journal:  J Biol Chem       Date:  1971-10-10       Impact factor: 5.157

5.  Soluble cytochrome b 5 reductase from human erythrocytes.

Authors:  P G Passon; D E Hultquist
Journal:  Biochim Biophys Acta       Date:  1972-07-12

6.  Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency.

Authors:  P J Rosen; C Johnson; W G McGehee; E Beutler
Journal:  Ann Intern Med       Date:  1971-07       Impact factor: 25.391

7.  Preparation and properties of the isolated alpha and beta chains of human hemoglobin in the ferri state. Investigation of oxidation-reduction equilibria.

Authors:  R Banerjee; R Cassoly
Journal:  J Mol Biol       Date:  1969-06-14       Impact factor: 5.469

8.  Kinetic studies on methemoglobin reduction by human red cell NADH cytochrome b5 reductase.

Authors:  A Tomoda; T Yubisui; A Tsuji; Y Yoneyama
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

9.  Changes in intermediate haemoglobins during methaemoglobin reduction by NADPH-flavin reductase.

Authors:  A Tomoda; T Yubisui; A Tsuji; Y Yoneyama
Journal:  Biochem J       Date:  1979-04-01       Impact factor: 3.857

10.  Characterization of intermediate hemoglobin produced during methemoglobin reduction by ascorbic acid.

Authors:  A Tomoda; M Takeshita; Y Yoneyama
Journal:  J Biol Chem       Date:  1978-10-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.